Antithrombotic Therapy by Regulating the ROS-Mediated Thrombosis Microenvironment and Specific Nonpharmaceutical Thrombolysis Using Prussian Blue Nanodroplets.
Antithrombotic Therapy by Regulating the ROS-Mediated Thrombosis Microenvironment and Specific Nonpharmaceutical Thrombolysis Using Prussian Blue Nanodroplets.
复制标题
通过调节 ROS 介导的血栓形成微环境和使用普鲁士蓝纳米液滴进行特异性非药物溶栓进行抗血栓治疗。
DOI:
10.1002/smll.202106252
复制
发表时间:
2022-03
期刊:
影响因子:
13.3
通讯作者:
Dajing Guo
中科院分区:
文献类型:
--
作者:
Wenli Zhang;Junrui Wang;Zhuoyan Xie;Hongmi Zou;Qiaoqi Chen;Lian Xu;Liu Hu;Ni Fang;Jie Xu;Jun Zhou;Jia Liu;Haitao Ran;Zhigang Wang;Yu Zhang;Dajing Guo
In thrombotic diseases, the effects of reactive oxygen species (ROS)-mediated oxidative stress as a "perpetrator" in thrombosis must be resolved. Accordingly, an insufficient understanding of thrombus therapy prompted the authors to pursue a more comprehensive and efficient antithrombotic treatment strategy. A Prussian blue (PB)-based nanodroplet system (PB-PFP@PC) is designed using PB and perfluorinated pentane (PFP) in the core, and a targeting peptide (CREKA, Cys-Arg-Glu-Lys-Ala) is attached to poly(lactic-coglycolic acid) (PLGA) as the delivery carrier shell. Upon near-infrared (NIR) laser irradiation, PB and PFP jointly achieve an unprecedented dual strategy for drug-free thrombolysis: photothermal therapy (PTT) combined with optical droplet vaporization (ODV). PB, a nanoenzyme, also regulates the vascular microenvironment via its antioxidant activity to continuously scavenge abnormally elevated ROS and correspondingly reduce inflammatory factors in the thrombus site. This study provides a demonstration of not only the potential of ODV in thrombus therapy but also the mechanism underlying PTT thrombolysis due to thermal ablation-induced fibrin network structural damage. Moreover, PB catalyzes ROS to generate oxygen (O2 ), which combines with the ODV effect, enhancing the ultrasound signal. Thus, regulation of the thrombosis microenvironment combined with specific nonpharmaceutical thrombolysis by PB nanodroplets provides a more comprehensive and efficient antithrombotic therapeutic strategy.
登录
查看更多内容
影响因子:
17.1
作者:
Jianpei Xu;Xiaoqi Wang;Haoyuan Yin;Xiang Cao;Quanyin Hu;Wei Lv;Qunwei Xu;Zhen Gu;Hongliang Xin
通讯作者:
Hongliang Xin
影响因子:
11.4
作者:
Qiao J;Arthur JF;Gardiner EE;Andrews RK;Zeng L;Xu K
通讯作者:
Xu K
影响因子:
4.9
作者:
Liang, Xiaolong;Deng, Zijian;Huang, Maomao
通讯作者:
Huang, Maomao
影响因子:
39.3
作者:
Gong, Zhuoran;Chen, Min;Dai, Zhifei
通讯作者:
Dai, Zhifei
影响因子:
5.6
作者:
Estelrich J;Busquets MA
通讯作者:
Busquets MA